The cellular level of histone H3 lysine 4 dimethylation correlates with response to adjuvant gemcitabine in Japanese pancreatic cancer patients treated with surgery.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Surgical Oncology

• Publication date

  2012-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejso.2012.08.008PMID 22959167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.

  2010cited by this paper
• Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients

  2009cited by this paper
• Distribution of gemcitabine pathway genotypes in ethnic Asians and their association with outcome in non-small cell lung cancer patients.

  2009cited by this paper
• Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

  2008cited by this paper
• The Global Histone Modification Pattern Correlates with Cancer Recurrence and Overall Survival in Gastric Adenocarcinoma

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• The role of chromatin during transcription.

  2007cited by this paper
• Global histone modifications predict prognosis of resected non small-cell lung cancer.

  2007cited by this paper
• PRDM5 Identified as a Target of Epigenetic Silencing in Colorectal and Gastric Cancer

  2007cited by this paper
• Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2

  2005cited by this paper
• Global histone modification patterns predict risk of prostate cancer recurrence

  2005cited by this paper
• Functional and genetic diversity in the concentrative nucleoside transporter, CNT1, in human populations.

  2004cited by this paper
• Identification and analysis of single-nucleotide polymorphisms in the gemcitabine pharmacologic pathway

  2004cited by this paper
• A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin.

  2004cited by this paper
• Human Cytidine Deaminase: Understanding the Catalytic Mechanism

  2003cited by this paper
• Critical Role of Histone Methylation in Tumor Suppressor Gene Silencing in Colorectal Cancer

  2003cited by this paper
• Histone H3 lysine 9 methylation occurs rapidly at the onset of random X chromosome inactivation.

  2002cited by this paper
• Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.

  2002cited by this paper
• Crystal structure of the tetrameric cytidine deaminase from Bacillus subtilis at 2.0 A resolution.

  2002cited by this paper
• Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation.

  2001cited by this paper
• Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

  1997cited by this paper
• Ethnic Differences in Drug Disposition and Responsiveness

  1991cited by this paper
• Core histone acetylation during lymphocyte activation

  1989cited by this paper
• Histone acetylation: a step in gene activation.

  1988cited by this paper
• Activation of chromatin by acetylation of histone side chains.

  1976cited by this paper

• Epigenetic dysregulation in pancreatic cancer: emerging biomarkers and clinical applications

  2025cites this paper
• Extracellular Vesicle‐Mediated Regulation of H3C14 Contributes to Gemcitabine Resistance in Bladder Cancer

  2025cites this paper
• Exploring the biological mechanism and clinical value of perineural invasion in pancreatic cancer.

  2025cites this paper
• Detection of metabolic adaptation in a triple-negative breast cancer animal model with [18F]choline-PET imaging as a surrogate for drug resistance

  2023cites this paper
• Progress on diagnostic and prognostic markers of pancreatic cancer

  2023cites this paper
• Inhibition of KDM5B participates in immune microenvironment remodeling in pancreatic cancer by inducing STING expression.

  2023cites this paper
• Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• Gene expression and epigenetic markers of prion diseases

  2022cites this paper
• Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response

  2021cites this paper
• H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy

  2019cites this paper
• Epigenetic alterations as biomarkers in pancreatic ductal adenocarcinoma

  2017cites this paper
• Drug metabolism and pancreatic cancer

  2016cites this paper
• Histone Methylation by Temozolomide; A Classic DNA Methylating Anticancer Drug.

  2016cites this paper
• Epigenetic alternations and cancer chemotherapy response

  2016cites this paper
• Whole Blood Measurement of Histone Modifications Linked to the Epigenetic Regulation of Gene Expression

  2015cites this paper
• Altered global histone-trimethylation code and H3F3A-ATRX mutation in pediatric GBM

  2015cites this paper
• Le point sur hENT1, autres biomarqueurs

  2015cites this paper
• Contemporary proteomic strategies for clinical epigenetic research and potential impact for the clinic

  2015influential citation
• Epigenetic perspectives on cancer chemotherapy response.

  2014cites this paper
• Influence of perineural invasion on survival and recurrence in patients with resected pancreatic cancer.

  2013cites this paper
• Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas

  2013cites this paper
• Methylation is associated with chemosensitivity to fluorouracil in patients with advanced gastric cancer

  year unknowncites this paper